Compare PGEN & TLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PGEN | TLS |
|---|---|---|
| Founded | 1998 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 317.1M |
| IPO Year | 2013 | 2020 |
| Metric | PGEN | TLS |
|---|---|---|
| Price | $3.97 | $4.17 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $8.33 | $7.90 |
| AVG Volume (30 Days) | ★ 5.1M | 901.4K |
| Earning Date | 05-13-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 31.51 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $230,981,000.00 | $164,805,000.00 |
| Revenue This Year | $1,115.92 | $18.72 |
| Revenue Next Year | $81.04 | $14.62 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 52.21 |
| 52 Week Low | $1.12 | $1.83 |
| 52 Week High | $5.47 | $8.36 |
| Indicator | PGEN | TLS |
|---|---|---|
| Relative Strength Index (RSI) | 54.48 | 45.21 |
| Support Level | $3.31 | $3.88 |
| Resistance Level | $4.44 | $4.69 |
| Average True Range (ATR) | 0.31 | 0.25 |
| MACD | 0.11 | 0.02 |
| Stochastic Oscillator | 74.09 | 45.93 |
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.